Anupam Rasayan inks MoU with 3xper Innoventure for new age pharma molecules

Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemicals manufacturer, inks Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a subsidiary of Tube Investments of India Limited a leading business conglomerates of India for supply of targeted and identified new age pharma molecules. The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO […]